<VariationArchive VariationID="90" VariationName="NM_021828.5(HPSE2):c.57dup (p.Ala20fs)" VariationType="Duplication" Accession="VCV000000090" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-05-19" DateCreated="2017-04-21" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15129" VariationID="90">
      <GeneList>
        <Gene Symbol="HPSE2" FullName="heparanase 2 (inactive)" GeneID="60495" HGNC_ID="HGNC:18374" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="98457077" stop="99315951" display_start="98457077" display_stop="99315951" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="100216833" stop="100995631" display_start="100216833" display_stop="100995631" Strand="-" />
          </Location>
          <OMIM>613469</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_021828.5(HPSE2):c.57dup (p.Ala20fs)</Name>
      <CanonicalSPDI>NC_000010.11:99235745:GGGGGGG:GGGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="99235745" stop="99235746" display_start="99235745" display_stop="99235746" variantLength="1" positionVCF="99235745" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="100995502" stop="100995503" display_start="100995502" display_stop="100995503" variantLength="1" positionVCF="100995502" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>A20fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021828.4" sequenceAccession="NM_021828" sequenceVersion="4" change="c.57dupC">
            <Expression>NM_021828.4:c.57dupC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.100995509dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.100995509dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.99235752dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.99235752dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_023416.1" sequenceAccession="NG_023416" sequenceVersion="1" change="g.5130dup">
            <Expression>NG_023416.1:g.5130dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166244.1" sequenceAccession="NM_001166244" sequenceVersion="1" change="c.57dup">
            <Expression>NM_001166244.1:c.57dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159716.1" sequenceAccession="NP_001159716" sequenceVersion="1" change="p.Ala20fs">
            <Expression>NP_001159716.1:p.Ala20fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166245.1" sequenceAccession="NM_001166245" sequenceVersion="1" change="c.57dup">
            <Expression>NM_001166245.1:c.57dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159717.1" sequenceAccession="NP_001159717" sequenceVersion="1" change="p.Ala20fs">
            <Expression>NP_001159717.1:p.Ala20fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166246.1" sequenceAccession="NM_001166246" sequenceVersion="1" change="c.57dup">
            <Expression>NM_001166246.1:c.57dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159718.1" sequenceAccession="NP_001159718" sequenceVersion="1" change="p.Ala20fs">
            <Expression>NP_001159718.1:p.Ala20fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021828.5" sequenceAccession="NM_021828" sequenceVersion="5" change="c.57dup" MANESelect="true">
            <Expression>NM_021828.5:c.57dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_068600.4" sequenceAccession="NP_068600" sequenceVersion="4" change="p.Ala20fs">
            <Expression>NP_068600.4:p.Ala20fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613469.0008" DB="OMIM" />
        <XRef Type="rs" ID="778121647" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_021828.5(HPSE2):c.57dup (p.Ala20fs) AND Urofacial syndrome type 1" Accession="RCV000000110" Version="6">
        <ClassifiedConditionList TraitSetID="42">
          <ClassifiedCondition DB="MedGen" ID="CN033872">Urofacial syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-17" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_021828.5(HPSE2):c.57dup (p.Ala20fs) AND HPSE2-related disorder" Accession="RCV003415594" Version="4">
        <ClassifiedConditionList TraitSetID="91924">
          <ClassifiedCondition>HPSE2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-07" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-04-21" MostRecentSubmission="2023-11-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19669792</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20560210</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="42" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5090" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Urofacial syndrome type 1</ElementValue>
                <XRef ID="MONDO:0009368" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">UFS1</ElementValue>
                <XRef Type="MIM" ID="236730" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Urofacial syndrome (UFS) is characterized by prenatal or infantile onset of urinary bladder voiding dysfunction, abnormal facial movement with expression (resulting from abnormal co-contraction of the corners of the mouth and eyes), and often bowel dysfunction (constipation and/or encopresis). Bladder voiding dysfunction increases the risk for urinary incontinence, megacystis, vesicoureteric reflux, hydroureteronephrosis, urosepsis, and progressive renal impairment. In rare instances, an individual who has (a) a molecularly confirmed diagnosis and/or (b) an affected relative meeting clinical diagnostic criteria manifests only the characteristic facial features or only the urinary bladder voiding dysfunction (not both). Nocturnal lagophthalmos (incomplete closing of the eyes during sleep) appears to be a common and significant finding.</Attribute>
                <XRef ID="NBK154138" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23967498</ID>
                <ID Source="BookShelf">NBK154138</ID>
              </Citation>
              <XRef ID="2704" DB="Orphanet" />
              <XRef ID="CN033872" DB="MedGen" />
              <XRef ID="MONDO:0009368" DB="MONDO" />
              <XRef Type="MIM" ID="236730" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="91924" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70268" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HPSE2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">HPSE2-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20253" SubmissionDate="2017-03-25" DateLastUpdated="2017-04-21" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613469.0008_UROFACIAL SYNDROME 1" title="HPSE2, 1-BP INS, 57C_UROFACIAL SYNDROME 1" />
        <ClinVarAccession Accession="SCV000020253" DateUpdated="2017-04-21" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-06-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 sibs and a cousin from a large Turkish pedigree with urofacial syndrome (UFS1; 236730), previously reported by Aydogdu et al. (2010), Daly et al. (2010) identified homozygosity for a 1-bp insertion (57insC) in exon 1 of the HPSE2 gene, predicted to cause a frameshift and premature stop codon at residue 64. All 4 unaffected parents and 10 unaffected sibs were heterozygous for the mutation, which was not found in 96 Turkish controls.</Attribute>
              <Citation>
                <ID Source="PubMed">19669792</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">20560210</ID>
              </Citation>
              <XRef DB="OMIM" ID="236730" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPSE2" />
          </GeneList>
          <Name>HPSE2, 1-BP INS, 57C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 57C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613469.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">UROFACIAL SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7701483" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="17015745|HPSE2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004116376" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The HPSE2 c.57dupC variant is predicted to result in a frameshift and premature protein termination (p.Ala20Argfs*45). This variant was reported in the homozygous state in five affected members of a family with urofacial syndrome. The variant was reported to segregate with disease in the family (Daly et al. 2010. PubMed ID: 20560210). This variant is reported in 0.019% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-100995502-C-CG). Frameshift variants in HPSE2 are expected to be pathogenic. Taken together, this variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPSE2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_021828.4:c.57dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HPSE2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5459369" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_021828.5:c.57dup|OMIM:236730" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002804761" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_021828.5:c.57dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="236730" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7701483" TraitType="Disease" MappingType="Name" MappingValue="HPSE2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="HPSE2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="20253" TraitType="Disease" MappingType="Name" MappingValue="UROFACIAL SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="CN033872" Name="Urofacial syndrome type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5459369" TraitType="Disease" MappingType="XRef" MappingValue="236730" MappingRef="OMIM">
        <MedGen CUI="CN033872" Name="Urofacial syndrome type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

